Friday, December 23, 2016 11:03:43 AM
Regarding the "news" that they are selling the entity that they are selling, I never even knew about it, clearly they were never doing much with it and I doubt it's sale is of little consequence. This pps increase I believe is unrelated. Frankly I think the pps was simply under where it should have been and if this continues on a mild increase, that'll just be a correction.
The main focus will always be emesyl. And so far, despite many true and good efforts, emesyl has yet to grow wings.
I did recently recommend emesyl to a friend, since I actually had very good results from it. It's fascinating that you can have a product which genuinely works, plus be actively trying to sell it, and yet still not go anywhere.
I'm not selling my stock till I get my buy in price from two years ago- 3 cents.
Someday I believe it WILL get there.
Happy 2017 everyone.
FEATURED Cannabix Technologies Launches New Compact Breath Logix Workplace Series and Prepares for Delivery to South Africa • May 7, 2024 8:51 AM
Epazz plans to spin off Galaxy Batteries Inc. • EPAZ • May 8, 2024 7:05 AM
Moon Equity Holdings, Corp. Announces Acquisition of Wikolo, Inc. • MONI • May 7, 2024 9:48 AM
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM